For patients with higher starting BMI, significant insulin resistance, or prior semaglutide plateau, tirzepatide often delivers the breakthrough
It doesnt include very much like drugs that could be repurposed for tropical diseases, for example
Patients consuming significantly fewer calories or eating at different times may experience hunger-related awakenings or changes in their usual sleep-wake cycle
Eligibility and FDA Approval Tirzepatide is FDA-approved for adults with a BMI of 30 or above, or 27 and above with at least one weight-related health condition, things like high blood pressure, type 2 diabetes, or sleep apnea
The New England Journal of Medicine, 387(3), 205216
If you are currently taking medications, have existing health conditions, are pregnant or nursing, or are considering any major changes to your health regimen, consult your physician before starting GLP-1 treatment or any new prescription medication